GBASE Showcases at CHIMA 2024, Exploring New Advances in Digital and Smart Healthcare
From May 17 to 19, the 28th Annual Academic Conference—China Hospital Information Network Conference (CHIMA 2024)—was successfully held at the Nanjing International Exhibition Center. At this premier annual event for healthcare IT, GBASE presented its full-stack, self-controllable database products and high-performance healthcare IT Application Innovation solutions, becoming a key highlight of the exhibition.
As a high-standard, high-profile industry event with a strong academic atmosphere in healthcare informatization, this year's conference was guided by the theory of new quality productive forces. Centered on the theme of "Deepening Application, Integrative Innovation, Empowering High-Quality Hospital Development with Information Technology," it brought together officials, hospital administrators, IT experts, scholars, and other professionals. They shared insights on hot topics and trends in healthcare IT from policy, practical, academic, and industrial perspectives, charting the course for the industry's future.
GBASE Drives High-Quality Development in Healthcare IT Application Innovation and Digital Transformation
As the cornerstone of public welfare, the digital transformation of healthcare is a crucial pathway to improving management and service capabilities. China's National Health Commission's "14th Five-Year Plan for National Health Informatization" explicitly lists "security and controllability" as a guiding principle. Choosing secure, reliable, stable, and efficient domestic database software has therefore become a focal point in healthcare IT Application Innovation.
The integrated development of digitalization and IT Application Innovation in the healthcare industry is an emerging trend. In recent years, GBASE has focused on creating multi-scenario healthcare IT Application Innovation solutions, collaborating with specialized ecosystem partners to promote high-quality growth in the sector.
To enhance the monitoring systems for infectious disease outbreaks and public health emergencies, improve the surveillance mechanisms for unexplained diseases and abnormal health events, boost evaluation sensitivity and accuracy, and establish an intelligent multi-trigger early warning system, GBASE has partnered with ecosystem collaborators. We have launched a GBase-based integrated solution for a national intelligent monitoring and early warning front-end processor for infectious diseases. This solution helps hospitals at all levels quickly deploy software and hardware that meet operational and management requirements, facilitates data exchange between medical institutions' information systems and the infectious disease monitoring system, and establishes a robust mechanism for automatically acquiring data like infectious disease diagnoses and pathogen test results, thus providing strong support for infectious disease prevention and control.
Furthermore, by leveraging a big data platform that integrates a data warehouse and data lake built on GBase, we support pharmaceutical R&D and clinical governance through deep mining of medical data's value. Simultaneously, GBASE provides database migration and data synchronization tools to help hospitals achieve a smooth migration and dual-track parallel operation of core medical business systems. This aids in building a self-controllable core system and ensures business continuity.
At the exhibition, focusing on the specific characteristics of medical data, GBASE showcased its cutting-edge GBase core products, IT Application Innovation solutions, and practical cases across various industries, attracting numerous healthcare IT experts and leaders for discussion and exchange.
As the digital transformation and IT Application Innovation in the healthcare sector deepen, the importance of databases becomes increasingly pronounced. As an industry-leading domestic database provider, GBASE will remain committed to independent R&D of core technologies. Driven by technological innovation and guided by real-world scenarios, we will actively respond to the national call to develop new quality productive forces in healthcare, continuously inject innovative momentum into the medical industry, and build a solid data foundation.